CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression.

CHD7 is one of nine members of the chromodomain helicase DNA-binding domain family of ATP-dependent chromatin remodeling enzymes found in mammalian cells. De novo mutation of CHD7 is a major cause of CHARGE syndrome, a genetic condition characterized by multiple congenital anomalies. To gain insight...

Full description

Bibliographic Details
Main Authors: Michael P Schnetz, Lusy Handoko, Batool Akhtar-Zaidi, Cynthia F Bartels, C Filipe Pereira, Amanda G Fisher, David J Adams, Paul Flicek, Gregory E Crawford, Thomas Laframboise, Paul Tesar, Chia-Lin Wei, Peter C Scacheri
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-07-01
Series:PLoS Genetics
Online Access:http://europepmc.org/articles/PMC2904778?pdf=render
_version_ 1828856403125600256
author Michael P Schnetz
Lusy Handoko
Batool Akhtar-Zaidi
Cynthia F Bartels
C Filipe Pereira
Amanda G Fisher
David J Adams
Paul Flicek
Gregory E Crawford
Thomas Laframboise
Paul Tesar
Chia-Lin Wei
Peter C Scacheri
author_facet Michael P Schnetz
Lusy Handoko
Batool Akhtar-Zaidi
Cynthia F Bartels
C Filipe Pereira
Amanda G Fisher
David J Adams
Paul Flicek
Gregory E Crawford
Thomas Laframboise
Paul Tesar
Chia-Lin Wei
Peter C Scacheri
author_sort Michael P Schnetz
collection DOAJ
description CHD7 is one of nine members of the chromodomain helicase DNA-binding domain family of ATP-dependent chromatin remodeling enzymes found in mammalian cells. De novo mutation of CHD7 is a major cause of CHARGE syndrome, a genetic condition characterized by multiple congenital anomalies. To gain insights to the function of CHD7, we used the technique of chromatin immunoprecipitation followed by massively parallel DNA sequencing (ChIP-Seq) to map CHD7 sites in mouse ES cells. We identified 10,483 sites on chromatin bound by CHD7 at high confidence. Most of the CHD7 sites show features of gene enhancer elements. Specifically, CHD7 sites are predominantly located distal to transcription start sites, contain high levels of H3K4 mono-methylation, found within open chromatin that is hypersensitive to DNase I digestion, and correlate with ES cell-specific gene expression. Moreover, CHD7 co-localizes with P300, a known enhancer-binding protein and strong predictor of enhancer activity. Correlations with 18 other factors mapped by ChIP-seq in mouse ES cells indicate that CHD7 also co-localizes with ES cell master regulators OCT4, SOX2, and NANOG. Correlations between CHD7 sites and global gene expression profiles obtained from Chd7(+/+), Chd7(+/-), and Chd7(-/-) ES cells indicate that CHD7 functions at enhancers as a transcriptional rheostat to modulate, or fine-tune the expression levels of ES-specific genes. CHD7 can modulate genes in either the positive or negative direction, although negative regulation appears to be the more direct effect of CHD7 binding. These data indicate that enhancer-binding proteins can limit gene expression and are not necessarily co-activators. Although ES cells are not likely to be affected in CHARGE syndrome, we propose that enhancer-mediated gene dysregulation contributes to disease pathogenesis and that the critical CHD7 target genes may be subject to positive or negative regulation.
first_indexed 2024-12-13T01:15:00Z
format Article
id doaj.art-3ef928e6540f4796bd63a464c5b0a4ee
institution Directory Open Access Journal
issn 1553-7390
1553-7404
language English
last_indexed 2024-12-13T01:15:00Z
publishDate 2010-07-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Genetics
spelling doaj.art-3ef928e6540f4796bd63a464c5b0a4ee2022-12-22T00:04:22ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042010-07-0167e100102310.1371/journal.pgen.1001023CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression.Michael P SchnetzLusy HandokoBatool Akhtar-ZaidiCynthia F BartelsC Filipe PereiraAmanda G FisherDavid J AdamsPaul FlicekGregory E CrawfordThomas LaframboisePaul TesarChia-Lin WeiPeter C ScacheriCHD7 is one of nine members of the chromodomain helicase DNA-binding domain family of ATP-dependent chromatin remodeling enzymes found in mammalian cells. De novo mutation of CHD7 is a major cause of CHARGE syndrome, a genetic condition characterized by multiple congenital anomalies. To gain insights to the function of CHD7, we used the technique of chromatin immunoprecipitation followed by massively parallel DNA sequencing (ChIP-Seq) to map CHD7 sites in mouse ES cells. We identified 10,483 sites on chromatin bound by CHD7 at high confidence. Most of the CHD7 sites show features of gene enhancer elements. Specifically, CHD7 sites are predominantly located distal to transcription start sites, contain high levels of H3K4 mono-methylation, found within open chromatin that is hypersensitive to DNase I digestion, and correlate with ES cell-specific gene expression. Moreover, CHD7 co-localizes with P300, a known enhancer-binding protein and strong predictor of enhancer activity. Correlations with 18 other factors mapped by ChIP-seq in mouse ES cells indicate that CHD7 also co-localizes with ES cell master regulators OCT4, SOX2, and NANOG. Correlations between CHD7 sites and global gene expression profiles obtained from Chd7(+/+), Chd7(+/-), and Chd7(-/-) ES cells indicate that CHD7 functions at enhancers as a transcriptional rheostat to modulate, or fine-tune the expression levels of ES-specific genes. CHD7 can modulate genes in either the positive or negative direction, although negative regulation appears to be the more direct effect of CHD7 binding. These data indicate that enhancer-binding proteins can limit gene expression and are not necessarily co-activators. Although ES cells are not likely to be affected in CHARGE syndrome, we propose that enhancer-mediated gene dysregulation contributes to disease pathogenesis and that the critical CHD7 target genes may be subject to positive or negative regulation.http://europepmc.org/articles/PMC2904778?pdf=render
spellingShingle Michael P Schnetz
Lusy Handoko
Batool Akhtar-Zaidi
Cynthia F Bartels
C Filipe Pereira
Amanda G Fisher
David J Adams
Paul Flicek
Gregory E Crawford
Thomas Laframboise
Paul Tesar
Chia-Lin Wei
Peter C Scacheri
CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression.
PLoS Genetics
title CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression.
title_full CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression.
title_fullStr CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression.
title_full_unstemmed CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression.
title_short CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression.
title_sort chd7 targets active gene enhancer elements to modulate es cell specific gene expression
url http://europepmc.org/articles/PMC2904778?pdf=render
work_keys_str_mv AT michaelpschnetz chd7targetsactivegeneenhancerelementstomodulateescellspecificgeneexpression
AT lusyhandoko chd7targetsactivegeneenhancerelementstomodulateescellspecificgeneexpression
AT batoolakhtarzaidi chd7targetsactivegeneenhancerelementstomodulateescellspecificgeneexpression
AT cynthiafbartels chd7targetsactivegeneenhancerelementstomodulateescellspecificgeneexpression
AT cfilipepereira chd7targetsactivegeneenhancerelementstomodulateescellspecificgeneexpression
AT amandagfisher chd7targetsactivegeneenhancerelementstomodulateescellspecificgeneexpression
AT davidjadams chd7targetsactivegeneenhancerelementstomodulateescellspecificgeneexpression
AT paulflicek chd7targetsactivegeneenhancerelementstomodulateescellspecificgeneexpression
AT gregoryecrawford chd7targetsactivegeneenhancerelementstomodulateescellspecificgeneexpression
AT thomaslaframboise chd7targetsactivegeneenhancerelementstomodulateescellspecificgeneexpression
AT paultesar chd7targetsactivegeneenhancerelementstomodulateescellspecificgeneexpression
AT chialinwei chd7targetsactivegeneenhancerelementstomodulateescellspecificgeneexpression
AT petercscacheri chd7targetsactivegeneenhancerelementstomodulateescellspecificgeneexpression